Company Overview and News

 
Aflac (AFL) Q1 Earnings to Gain From Higher US Segment Sales

2018-04-20 zacks
Aflac Inc. (AFL - Free Report) is scheduled to announce first-quarter 2018 results on Apr 25, after the closing bell. Its quarterly revenues and earnings are expected to improve year over year.
Upvote Downvote

1
10 Fairly Valued Dividend Growth Stocks For Total Return: Part 4

2018-04-19 seekingalpha
One misconception that I come across repeatedly is the idea that if the company’s growth rate increases, then so should its fair value multiple.
Upvote Downvote

 
American Express' (AXP) Billings, Loans to Aid Q1 Earnings

2018-04-17 zacks
American Express Company’s (AXP - Free Report) first-quarter 2018 results should see upside from accelerated growth in billings and continued strong growth in loans and fees. The company’s global commercial and global consumer segments represents 40% and 43% of billings, respectively, and Global Network Services makes up the remaining 17% of billings. In the fourth quarter, the company had witnessed record billings and strong loan growth, which helped drive a 10% increase in revenues.
Upvote Downvote

 
Best Stocks Below Their Graham Number - April 2018

2018-04-10 seekingalpha
All of these companies are rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach.
Upvote Downvote

 
Bert's March Dividend Income Summary

2018-04-08 seekingalpha
Wow. What a month it has been. My busy season came to a roaring close, there was an insane number of March Madness upsets, and my personal favorite baseball season is back! One of my favorite activities each month is sitting down with a nice beverage and aggregating my final dividend results for the month. I tally the results throughout the month, but there is something exciting about finalizing my totals and seeing the final amount of dividend income received and calculating my year-over-year growth rate.
Upvote Downvote

 
AFLAC Incorporated (AFL) Dividend Stock Analysis

2018-04-07 valuewalk
Aflac Incorporated (AFL), through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance. The company is a member of the dividend aristocrats’ index, has paid dividends since 1973 and increased them for 36 years in a row.
Upvote Downvote

 
Best Dividend Paying Stocks For Dividend Growth Investors - April 2018

2018-04-04 seekingalpha
These companies are all rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach.
Upvote Downvote

 
Dividend Growth 50: Not Perfect, But Yet Another 8% Raise

2018-04-02 seekingalpha
Pepsi and Clorox are among the DG50 companies to have announced nice dividend hikes for the year ahead.
Upvote Downvote

1
5 Low P/E Companies In The S&P 500

2018-03-29 seekingalpha
These companies are all rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach.
Upvote Downvote

 
Should You Get Rid of Amerisafe (AMSF) Now?

2018-03-27 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.
Upvote Downvote

 
Top Research Reports for Oracle, Vale & General Mills

2018-03-23 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Vale (VALE) and General Mills (GIS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Upvote Downvote

 
AFL / AFLAC, Inc. 8-K (Current Report)

2018-03-23 sec.gov
Document UNITED STATES
Upvote Downvote

1
5 Undervalued Large-Cap Stocks For Value Investors - March 2018

2018-03-22 seekingalpha
NWL, VZ, GILD, PFG, and AFL are all rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 001055102